And So It Begins... FDA PRESS RELEASE The U.S. Food and Drug Administration (FDA) has approved four vaccines for use against the 2009 H1N1 influenza virus. The vaccines—made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur … [Read more...] about FDA Approves Vaccines for H1N1 Influenza Virus
H1N1 "swine flu" virus
Australia’s swine flu vaccination plans come under fire
"It’s a complex issue which needs to be thrashed out publicly. We’d encourage the key bodies involved to have that debate, to provide that information. Consumers want to know the facts." — Carol Bennett, the head of the Consumers Health Forum of Australia The Australian … [Read more...] about Australia’s swine flu vaccination plans come under fire
Rice Researchers Seek Better Vaccine Procedure to Target Flu Viruses
The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them. As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for … [Read more...] about Rice Researchers Seek Better Vaccine Procedure to Target Flu Viruses
BioSante Pharmaceuticals’ BioVantTM Adjuvanted Vaccine Reports 100% Protection From H1N1 Virus
BioSante's vaccine adjuvant, BioVantTM, increases the protective effect of vaccines for multiple flu strains BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today's presentation of H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. … [Read more...] about BioSante Pharmaceuticals’ BioVantTM Adjuvanted Vaccine Reports 100% Protection From H1N1 Virus
AstraZeneca Cashes In On Global Swine Flu Windfall
Pandemic offers AZ a blockbuster return Anyone who still thinks that AstraZeneca paid too much when it offered a hefty premium for MedImmune's shares should check out a new report from Jefferies International, which estimates that the global swine flu windfall will be worth … [Read more...] about AstraZeneca Cashes In On Global Swine Flu Windfall